Krsnaa Diagnostics Reappoints Executive Chairman Rajendra Mutha for Five-Year Term

An announcement from Krsnaa Diagnostics Limited ( (IN:KRSNAA) ) is now available.

Krsnaa Diagnostics Limited has approved the re-appointment of Mr. Rajendra Khivraj Mutha as Whole-time Director and Chairman, designated as Executive Chairman, for a further five-year term starting April 26, 2026 and ending April 25, 2031. The decision, based on the Nomination and Remuneration Committee’s recommendation and compliant with Indian corporate and securities regulations, underscores continuity in strategic leadership and governance for the diagnostics provider.

Mr. Mutha brings over two decades of experience in pharmacy and diagnostics and is credited with driving the company’s strategic vision, operational excellence and community-focused health initiatives. His renewed tenure is expected to reinforce Krsnaa Diagnostics’ CSR-driven growth, maintain regulatory confidence—supported by confirmation that he is not debarred by SEBI or other authorities—and provide stability for stakeholders as the company pursues its healthcare expansion goals.

More about Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited operates in the healthcare diagnostics sector, providing pathology and radiology services across India. The company focuses on accessible and affordable diagnostic solutions, leveraging medical expertise and outreach initiatives to serve underserved communities and strengthen its position as a trusted healthcare partner.

Average Trading Volume: 3,871

Technical Sentiment Signal: Sell

Current Market Cap: 21.56B INR

Learn more about KRSNAA stock on TipRanks’ Stock Analysis page.